Integrins α5β1, αvβ1, and αvβ6 collaborate in squamous carcinoma cell spreading and migration on fibronectin

被引:43
作者
Koivisto, L
Grenman, R
Heino, J
Larjava, H
机构
[1] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada
[2] Univ Turku, Dept Otorhinolaryngol Head & Neck Surg, Turku, Finland
[3] Univ Turku, Dept Med Biochem, Turku, Finland
[4] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland
基金
芬兰科学院; 英国医学研究理事会;
关键词
integrins; squamous cell carcinoma; cell spreading; cell migration;
D O I
10.1006/excr.1999.4769
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The expression of alpha v beta 6 fibronectin/tenascin receptor integrin is induced in malignant transformation of oral epithelium. In this study, we demonstrate the contribution of alpha v beta 6 as well as other fibronectin receptor integrins in squamous cell carcinoma (SCC) cell adhesion and migration. Of 11 SCC cell lines isolated from the head and neck area, 8 (73%) expressed alpha v beta 6 integrin an the cell surface. Three cell lines were chosen for further functional experiments: 1 with relatively high, 1 with moderate, and 1 with minimal surface expression of alpha v beta 6 integrin. In addition to alpha v beta 6, all 3 cell lines expressed alpha 5 beta 1 and alpha v beta 1 fibronectin receptor integrins. Function-blocking experiments with inhibitory anti-integrin antibodies showed that all these three integrins were functional in SCC cell spreading on fibronectin. Integrin alpha v beta 6, however, was not used as a primary but as an alternative fibronectin receptor by SCC cells, as the inhibitory anti-beta 6 integrin antibody alone had no effect on spreading. In migration, however; alpha v beta 6, alpha 5 beta 1, and alpha v beta 1 integrins were all used in cooperation. The presence of alpha v beta 1 integrin in SCC cells is a novel finding as is its contribution to SCC cell migration. When one or two of these three receptors were blocked, the cells demonstrated an adaptive ability to remain migratory using integrins that were not targeted by antibodies. Utilization of a combination of receptors of different affinities may be beneficial for SCC cell migration versatility. (C) 2000 Academic Press.
引用
收藏
页码:10 / 17
页数:8
相关论文
共 52 条
[31]  
2-C
[32]   ONCOFETAL FIBRONECTINS IN ORAL CARCINOMAS - CORRELATION OF 2 DIFFERENT TYPES [J].
MANDEL, U ;
GAGGERO, B ;
REIBEL, J ;
THERKILDSEN, MH ;
DABELSTEEN, E ;
CLAUSEN, H .
APMIS, 1994, 102 (09) :695-702
[33]   The integrin αvβ6 binds and activates latent TGFβ1:: A mechanism for regulating pulmonary inflammation and fibrosis [J].
Munger, JS ;
Huang, XZ ;
Kawakatsu, H ;
Griffiths, MJD ;
Dalton, SL ;
Wu, JF ;
Pittet, JF ;
Kaminski, N ;
Garat, C ;
Matthay, MA ;
Rifkin, DB ;
Sheppard, D .
CELL, 1999, 96 (03) :319-328
[34]   Integrin-mediated signalling of gelatinase B secretion in colon cancer cells [J].
Niu, J ;
Gu, X ;
Turton, J ;
Meldrum, C ;
Howard, EW ;
Agrez, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 249 (01) :287-291
[35]   Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness [J].
Palecek, SP ;
Loftus, JC ;
Ginsberg, MH ;
Lauffenburger, DA ;
Horwitz, AF .
NATURE, 1997, 385 (6616) :537-540
[36]   LOCALIZATION OF INTEGRIN RECEPTORS FOR FIBRONECTIN, COLLAGEN, AND LAMININ IN HUMAN-SKIN - VARIABLE EXPRESSION IN BASAL AND SQUAMOUS-CELL CARCINOMAS [J].
PELTONEN, J ;
LARJAVA, H ;
JAAKKOLA, S ;
GRALNICK, H ;
AKIYAMA, SK ;
YAMADA, SS ;
YAMADA, KM ;
UITTO, J .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :1916-1923
[37]   MULTIPLE INTEGRINS MEDIATE CELL ATTACHMENT TO CYTOTACTIN TENASCIN [J].
PRIETO, AL ;
EDELMAN, GM ;
CROSSIN, KL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) :10154-10158
[38]   IDENTIFICATION AND ISOLATION OF A 140-KD CELL-SURFACE GLYCOPROTEIN WITH PROPERTIES EXPECTED OF A FIBRONECTIN RECEPTOR [J].
PYTELA, R ;
PIERSCHBACHER, MD ;
RUOSLAHTI, E .
CELL, 1985, 40 (01) :191-198
[39]  
Ramos DM, 1997, INT J CANCER, V72, P369, DOI 10.1002/(SICI)1097-0215(19970717)72:2<369::AID-IJC28>3.0.CO
[40]  
2-9